Trials / Conditions / DIPG Brain Tumor
DIPG Brain Tumor
6 registered clinical trials studyying DIPG Brain Tumor — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas NCT06465199 | Milton S. Hershey Medical Center | Phase 1 / Phase 2 |
| Recruiting | Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age NCT05956821 | University of Miami | Phase 1 / Phase 2 |
| Not Yet Recruiting | Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma NCT06396481 | Beijing Tiantan Hospital | EARLY_Phase 1 |
| Recruiting | Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG NCT06221553 | Chulalongkorn University | Phase 1 |
| Terminated | Oral AMXT 1501 Dicaprate in Combination With IV DFMO NCT05500508 | Aminex Therapeutics, Inc. | Phase 1 / Phase 2 |
| No Longer Available | Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment NCT06439849 | Petrov, Andrey | — |